Oct 9, 2017
By Honor Whiteman
Published on www.medicalnewstoday.com
The risk of stroke could be increased by more than a quarter for people who experience migraine with aura. So concludes a twin study recently published in the journal Brain.
According to the Migraine Research Foundation, around 39 million children and adults in the United States are affected by migraine, a disorder characterized by the recurrence of moderate or severe throbbing pain on one or both sides of the head. (more…)
Oct 4, 2017
Jon Barrick, SAFE President, invites stroke advocates from European stroke support organisations to step forward and register for the Munich consensus conference – March 2018
The“Action Plan for Stroke in Europe 2018 to 2030” will be of major importance for the prevention of stroke in Europe and the implementation of adequate stroke services including life after stroke. Two previous consensus conferences on stroke management in Europe (1995 and 2006) laid foundations, and this initiative will modernise the actions that need to be implemented.
The third consensus conference is scheduled to take place in Munich in 2018, building on the experience and the format of the previous conferences. The conference will be organized by the European Stroke Organisation, in partnership with the Stroke Alliance for Europe (SAFE). The World Health Organization will be asked to endorse the conference. (more…)
Oct 2, 2017
Victoria Brewer, SSOFT Project and Organisation Manager
This September, SAFE started developing a standalone tool Learning Management System (LMS) that can be accessed by SAFE members online in any location. This project’s title is
Stroke Support Organisation Faculty Tool (SSOFT)
The SAFE board approved the appointment of Victoria Brewer as SAFE Project and Organisation Director. We asked Victoria about this project, its main features and what would be the expected benefit for stroke support organisations.
(more…)
Sep 29, 2017
A national trial involving more than 8,000 patients has revealed that giving oxygen to stroke victims makes no difference to their recovery or chances of survival.
The study was led by Keele University’s stroke specialist Professor Christine Roffe, along with North Staffordshire Combined Healthcare NHS Trust and researchers from the University of Oxford and the University of Birmingham, and was funded by the National Institute for Health Research. (more…)
Sep 29, 2017
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered a new class of molecules in the brain that synchronize cell-to-cell communication and neuroinflammation/immune activity in response to injury or diseases. Elovanoids (ELVs) are bioactive chemical messengers made from omega-3 very long chain polyunsaturated fatty acids (VLC-PUFAs,n-3). They are released on demand when cells are damaged or stressed. (more…)